Category
All
New Technology
Service & Software
Internet & Communication
Electronics & Semiconductor
Pharma & Healthcare
Other
Energy & Power
Agriculture
Consumer Goods
Machinery & Equipment
Food & Beverages
Medical Care
Automobile & Transportation
Packaging
Chemical & Material
Medical Devices & Consumables
Category
All
Total: 5 records, 1 pages
Search For: chemotherapy induced peripheral neuropathy treatment
Global Chemotherapy Induced Peripheral Neuropathy Treatment Supply, Demand and Key Producers, 2024-2030
09 Feb 2024
Pharma & Healthcare
Chemotherapy Induced Peripheral Neuropathy Treatment
The global Chemotherapy Induced Peripheral Neuropathy Treatment market size is expected to reach $ 2613.1 million by 2030, rising at a market growth of 6.1% CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
Global Chemotherapy Induced Peripheral Neuropathy Treatment Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
02 Jan 2024
Pharma & Healthcare
Chemotherapy Induced Peripheral Neuropathy Treatment
According to our (Global Info Research) latest study, the global Chemotherapy Induced Peripheral Neuropathy Treatment market size was valued at USD 1723.6 million in 2023 and is forecast to a readjusted size of USD 2613.1 million by 2030 with a CAGR of 6.1% during review period.
USD3480.00
Add To Cart
Global Chemotherapy Induced Peripheral Neuropathy Treatment Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
18 Mar 2023
Pharma & Healthcare
Chemotherapy Induced Peripheral Neuropathy Treatment
CIPN is a common adverse effect of several cancer therapies including taxanes and platinum drugs. Symptoms include decreased sensation and tingling of the hands and feet, severe pain, numbness and muscle weakness, all of which can occur during cancer treatment, and frequently persist after chemotherapy has ended.
USD3480.00
Add To Cart
Global Chemotherapy Induced Peripheral Neuropathy Treatment Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
04 Jan 2022
Pharma & Healthcare
chemotherapy induced peripheral neuropathy treatment
The Chemotherapy Induced Peripheral Neuropathy Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
USD3480.00
Add To Cart
Global Chemotherapy Induced Peripheral Neuropathy Treatment Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
23 Mar 2021
Pharma & Healthcare
chemotherapy induced peripheral neuropathy treatment
The Chemotherapy Induced Peripheral Neuropathy Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
USD3480.00
Add To Cart
Popular Product Keywords
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
Search For: chemotherapy induced peripheral neuropathy treatment
Total: 5 records, 1 pages
The global Chemotherapy Induced Peripheral Neuropathy Treatment market size is expected to reach $ 2613.1 million by 2030, rising at a market growth of 6.1% CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
According to our (Global Info Research) latest study, the global Chemotherapy Induced Peripheral Neuropathy Treatment market size was valued at USD 1723.6 million in 2023 and is forecast to a readjusted size of USD 2613.1 million by 2030 with a CAGR of 6.1% during review period.
USD3480.00
Add To Cart
CIPN is a common adverse effect of several cancer therapies including taxanes and platinum drugs. Symptoms include decreased sensation and tingling of the hands and feet, severe pain, numbness and muscle weakness, all of which can occur during cancer treatment, and frequently persist after chemotherapy has ended.
USD3480.00
Add To Cart
The Chemotherapy Induced Peripheral Neuropathy Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
USD3480.00
Add To Cart
The Chemotherapy Induced Peripheral Neuropathy Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
USD3480.00
Add To Cart
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>